CHinese Acute Tissue-Based Imaging Selection for Lysis In Stroke -Tenecteplase II
Status:
Recruiting
Trial end date:
2022-12-31
Target enrollment:
Participant gender:
Summary
To explore the efficacy and safety of tenecteplase for acute ischemic stroke patients (onset
time 4.5-24h) of large vessel occlusion using early combined CT/MR imaging outcomes